ABSTRACT
BACKGROUND: Non-celiac wheat sensitivity (NCWS) is a poorly understood gluten-related disorder (GRD) and its prominent symptoms can be ameliorated by gluten avoidance. This study aimed to determine the effectiveness of a probiotic mixture in hydrolyzing gliadin peptides (toxic components of gluten) and suppressing gliadin-induced inflammatory responses in Caco-2 cells. METHODS: Wheat dough was fermented with a probiotic mix for 0, 2, 4, and 6 h. The effect of the probiotic mix on gliadin degradation was monitored by SDS-PAGE. The expression levels of IL-6, IL-17A, INF-γ, IL-10, and TGF-ß were evaluated using ELISA and qRT-PCR methods. RESULTS: According to our findings, fermenting wheat dough with a mix of B. longum, L. acidophilus, and L. plantarum for 6 h was effective in gliadin degradation. This process also reduced levels of IL-6 (p = 0.004), IL-17A (p = 0.004), and IFN-γ (p = 0.01) mRNA, as well as decreased IL-6 (p = 0.006) and IFN-γ (p = 0.0009) protein secretion. 4 h fermentation led to a significant decrease in IL-17A (p = 0.001) and IFN-γ (p = 0.003) mRNA, as well as reduced levels of IL-6 (p = 0.002) and IFN-γ (p < 0.0001) protein secretion. This process was also observed to increase the expression levels of IL-10 (p < 0.0001) and TGF-ß (p < 0.0001) mRNA. CONCLUSIONS: 4 h fermentation of wheat flour with the proposed probiotic mix might be a good strategy to develop an affordable gluten-free wheat dough for NCWS and probably other GRD patients.
Subject(s)
Celiac Disease , Gliadin , Humans , Gliadin/adverse effects , Caco-2 Cells , Hydrolysis , Interleukin-10 , Interleukin-17 , Celiac Disease/metabolism , Interleukin-6 , Flour , Triticum/metabolism , Glutens/adverse effects , Lactobacillus acidophilus , Transforming Growth Factor betaABSTRACT
The present study examined the wheat protein gliadin-induced oxidative and nitrosative stress and its downstream responses in human intestinal HCT-116 and HT-29 cells. The beneficial role of dietary phytochemical curcumin and role of multifunctional enzyme Apurinic/aprymidinic endonuclease 1 (APE1) a major player involved in the base excision repair (BER)-pathway in gliadin intolerant intestinal HCT-116 and HT-29 cell lines were evaluated as an in vitro model study. The cultured cells were exposed to gliadin protein, H2 O2 , and curcumin followed by the assessment of oxidative stress and the consequences were measured using spectrophotometric, PCR, flow cytometer, Western blotting, confocal microscopy, and other methods. Results demonstrate that a 3 h pretreatment of curcumin, followed by the treatment of gliadin protein for 24 h time period protected both the HCT-116 and HT-29 cells via: (i) decreasing the ROS/RNS, restoring the mitochondrial transmembrane potential; (ii) re-establishing the cellular antioxidant defense system (superoxide dismutase, catalase, and GSH); (iii) enhancing the functions of APE1 viz. endonuclease activity and redox activation of transcription factor Nrf-2, the later binds with the antioxidant response elements (ARE) and activates downstream targets involved in cell survival. The cross-talk between APE1 and Nrf-2 was also established using immunofluorescence imaging and co-immunoprecipitation assays. In conclusion, gliadin protein induces oxidative/nitrosative stress, mitochondrial dysfunction and it damages cellular biomolecules in the intestinal cells. Hence it can be attributed to the tissue damage and disease pathogenesis in wheat intolerance-associated intestinal diseases. The gliadin-induced stress and its consequences are significantly reduced by the pretreatment of curcumin via BER-pathway and ARE-pathway; which is evident through the interaction between these two essential proteins. Hence suggesting for the intervention of curcumin and other natural dietary phytochemicals-based disease management and treatment of gliadin intolerance associated intestinal diseases like celiac disease.
Subject(s)
Curcumin , DNA-(Apurinic or Apyrimidinic Site) Lyase , Gliadin , NF-E2-Related Factor 2 , Oxidative Stress , Curcumin/pharmacology , DNA Repair , DNA-(Apurinic or Apyrimidinic Site) Lyase/metabolism , Endonucleases/metabolism , Gliadin/adverse effects , Humans , Multifunctional Enzymes/metabolism , NF-E2-Related Factor 2/metabolism , Transcription Factors/metabolismABSTRACT
The autoimmune condition, Celiac Disease (CeD), displays broad clinical symptoms due to gluten exposure. Its genetic association with DQ variants in the human leukocyte antigen (HLA) system has been recognised. Monocyte-derived mature dendritic cells (MoDCs) present gluten peptides through HLA-DQ and co-stimulatory molecules to T lymphocytes, eliciting a cytokine-rich microenvironment. Having access to CeD associated families prevalent in the Czech Republic, this study utilised an in vitro model to investigate their differential monocyte profile. The higher monocyte yields isolated from PBMCs of CeD patients versus control individuals also reflected the greater proportion of dendritic cells derived from these sources following lipopolysaccharide (LPS)/ peptic-tryptic-gliadin (PTG) fragment stimulation. Cell surface markers of CeD monocytes and MoDCs were subsequently profiled. This foremost study identified a novel bio-profile characterised by elevated CD64 and reduced CD33 levels, unique to CD14++ monocytes of CeD patients. Normalisation to LPS stimulation revealed the increased sensitivity of CeD-MoDCs to PTG, as shown by CD86 and HLA-DQ flow cytometric readouts. Enhanced CD86 and HLA-DQ expression in CeD-MoDCs were revealed by confocal microscopy. Analysis highlighted their dominance at the CeD-MoDC membrane in comparison to controls, reflective of superior antigen presentation ability. In conclusion, this investigative study deciphered the monocytes and MoDCs of CeD patients with the identification of a novel bio-profile marker of potential diagnostic value for clinical interpretation. Herein, the characterisation of CD86 and HLA-DQ as activators to stimulants, along with robust membrane assembly reflective of efficient antigen presentation, offers CeD targeted therapeutic avenues worth further exploration.
Subject(s)
Antigen Presentation/immunology , Celiac Disease/immunology , Dendritic Cells/immunology , Gliadin/adverse effects , Adolescent , Adult , Aged , Antigens, CD/metabolism , Autoimmune Diseases/immunology , Biomarkers/metabolism , Celiac Disease/epidemiology , Cell Membrane/metabolism , Czech Republic/epidemiology , Disease Susceptibility , Family , Female , HLA-DQ Antigens/metabolism , Humans , Lipopolysaccharides , Male , Middle Aged , Monocytes/metabolism , Pedigree , T-Lymphocytes, Cytotoxic/immunology , Young AdultABSTRACT
Exposure to gluten, a protein present in wheat rye and barley, is the major inducer for human Celiac Disease (CD), a chronic autoimmune enteropathy. CD occurs in about 1% worldwide population, in genetically predisposed individuals bearing human leukocyte antigen (HLA) DQ2/DQ8. Gut epithelial cell stress and the innate immune activation are responsible for the breaking oral tolerance to gliadin, a gluten component. To date, the only treatment available for CD is a long-term gluten-free diet. Several studies have shown that an altered composition of the intestinal microbiota (dysbiosis) could play a key role in the pathogenesis of CD through the modulation of intestinal permeability and the regulation of the immune system. Here, we show that gliadin induces a chronic endoplasmic reticulum (ER) stress condition in the small intestine of a gluten-sensitive mouse model and that the coadministration of probiotics efficiently attenuates both the unfolded protein response (UPR) and gut inflammation. Moreover, the composition of probiotics formulations might differ in their activity at molecular level, especially toward the three axes of the UPR. Therefore, probiotics administration might potentially represent a new valuable strategy to treat gluten-sensitive patients, such as those affected by CD.
Subject(s)
Dietary Supplements , Endoplasmic Reticulum Stress , Food Intolerance/therapy , Gastrointestinal Tract/pathology , Gliadin/adverse effects , Glutens/adverse effects , Inflammation/pathology , Probiotics/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Caco-2 Cells , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Disease Models, Animal , Endoplasmic Reticulum Stress/drug effects , GTP-Binding Proteins/metabolism , Gastrointestinal Tract/drug effects , Humans , Mice, Inbred BALB C , Permeability , Probiotics/administration & dosage , Protein Glutamine gamma Glutamyltransferase 2 , Transglutaminases/metabolism , Up-RegulationABSTRACT
Celiac disease (CD) is a type of inflammatory chronic disease caused by nutrients such as gliadin that induce a TC (T cell)-mediated response in a partially known genetical background in an environment predisposed to inflammation, including viruses and food. Various experimental and clinical observations suggest that multiple agents such as viruses and bacteria have some common, inflammatory pathways predisposing individuals to chronic inflammatory diseases including celiac disease (CD). More recently, a Western diet and lifestyle have been linked to tissue inflammation and increase in chronic inflammatory diseases. In CD, the gliadin protein itself has been shown to be able to induce inflammation. A cooperation between viruses and gliadin is present in vitro and in vivo with common mechanisms to induce inflammation. Nutrients could have also a protective effect on CD, and in fact the anti-inflammatory Mediterranean diet has a protective effect on the development of CD in children. The possible impact of these observations on clinical practice is discussed.
Subject(s)
Celiac Disease/virology , Food/adverse effects , Viruses/metabolism , Celiac Disease/diet therapy , Diet, Mediterranean , Gliadin/adverse effects , Humans , Inflammation/pathologyABSTRACT
Coeliac disease (CD) is the prototype of an inflammatory chronic disease induced by food. In this context, gliadin p31-43 peptide comes into the spotlight as an important player of the inflammatory/innate immune response to gliadin in CD. The p31-43 peptide is part of the p31-55 peptide from α-gliadins that remains undigested for a long time, and can be present in the small intestine after ingestion of a gluten-containing diet. Different biophysical methods and molecular dynamic simulations have shown that p31-43 spontaneously forms oligomeric nanostructures, whereas experimental approaches using in vitro assays, mouse models, and human duodenal tissues have shown that p31-43 is able to induce different forms of cellular stress by driving multiple inflammatory pathways. Increased proliferative activity of the epithelial cells in the crypts, enterocyte stress, activation of TG2, induction of Ca2+, IL-15, and NFκB signaling, inhibition of CFTR, alteration of vesicular trafficking, and activation of the inflammasome platform are some of the biological effects of p31-43, which, in the presence of appropriate genetic susceptibility and environmental factors, may act together to drive CD.
Subject(s)
Gliadin/adverse effects , Inflammation/etiology , Peptide Fragments/adverse effects , Amino Acid Sequence , Animals , Disease Models, Animal , Gliadin/chemistry , Humans , Inflammasomes/metabolism , Inflammation/pathology , Peptide Fragments/chemistry , Signal Transduction , Triticum/chemistryABSTRACT
Celiac disease (CD) is an autoimmune enteropathy arising in genetically predisposed subjects exposed to gluten, which activates both innate and adaptive immunity. Although the pathogenesis is common to all patients, the clinical spectrum is quite variable, and differences could be explained by gene expression variations. Among the factors able to affect gene expression, there are lncRNAs. We evaluated the expression profile of 87 lncRNAs in CD vs. healthy control (HC) intestinal biopsies by RT-qPCR array. Nuclear enriched abundant transcript 1 (NEAT1) and taurine upregulated gene 1 (TUG1) were detected as downregulated in CD patients at diagnosis, but their expression increased in biopsies of patients on a gluten-free diet (GFD) exposed to gluten. The increase in NEAT1 expression after gluten exposure was mediated by IL-15 and STAT3 activation and binding to the NEAT1 promoter, as demonstrated by gel shift assay. NEAT1 is localized in the nucleus and can regulate gene expression by sequestering transcription factors, and it has been implicated in immune regulation and control of cell proliferation. The demonstration of its regulation by gluten thus also supports the role of lncRNAs in CD and prompts further research on these RNAs as gene expression regulators.
Subject(s)
Celiac Disease/genetics , Down-Regulation , Duodenum/chemistry , Gliadin/adverse effects , RNA, Long Noncoding/genetics , Adult , Case-Control Studies , Celiac Disease/immunology , Cell Proliferation , Cells, Cultured , Child , Down-Regulation/drug effects , Duodenum/immunology , Female , Gene Expression Regulation , Humans , Immunity, Innate , Interleukin-15/genetics , Intestinal Mucosa/chemistry , Intestinal Mucosa/immunology , Male , STAT3 Transcription Factor/geneticsABSTRACT
Celiac disease (CD) presents as chronic low-grade inflammation of the small intestine often characterized by psychiatric comorbidities. The brain-derived neurotrophic factor (BDNF), which we have shown to be reduced in the serum of CD patients, acts as the bridge between immune activation and the nervous system adaptive response. Since Lactobacillus has been shown to upregulate BDNF, this study aimed to evaluate whether the administration of Lactobacillus rhamnosus GG (L.GG) could positively affect the brain BDNF system in rats mimicking the CD lesions. Data have shown that the administration of pepsin-trypsin digested gliadin (PTG) and L.GG alter the levels of mature BDNF (mBDNF), as evaluated by Western blotting. PTG provoked a reduction of mBDNF compared to controls, and a compensatory increase of its receptor TrkB. L.GG induced a slight positive effect on mBDNF levels under normal conditions, while it was able to rescue the PTG-induced reduced expression of mBDNF. The curative effect of L.GG was finely tuned, accompanied by the reduction of TrkB, probably to avoid the effect of excessive BDNF.
Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Brain , Celiac Disease , Gliadin/adverse effects , Lacticaseibacillus rhamnosus , Receptor, trkB/biosynthesis , Animals , Brain/metabolism , Brain/pathology , Celiac Disease/chemically induced , Celiac Disease/metabolism , Celiac Disease/pathology , Gliadin/chemistry , Gliadin/pharmacology , Pepsin A , Rats , Rats, Wistar , TrypsinABSTRACT
A therapeutic gluten-free diet often has nutritional limitations. Nutritional qualities such as high protein content, the presence of biologically active and beneficial substances (fiber, beta-glucans, polyunsaturated fatty acids, essential amino acids, antioxidants, vitamins, and minerals), and tolerance by the majority of celiac patients make oat popular for use in gluten-free diet. The health risk of long-time consumption of oat by celiac patients is a matter of debate. The introduction of oat into the diet is only recommended for celiac patients in remission. Furthermore, not every variety of oat is also appropriate for a gluten-free diet. The risk of sensitization and an adverse immunologically mediated reaction is a real threat in some celiac patients. Several unsolved issues still exist which include the following: (1) determination of the susceptibility markers for the subgroup of celiac patients who are at risk because they do not tolerate dietary oat, (2) identification of suitable varieties of oat and estimating the safe dose of oat for the diet, and (3) optimization of methods for detecting the gliadin contamination in raw oat used in a gluten-free diet.
Subject(s)
Avena , Celiac Disease/diet therapy , Diet, Gluten-Free , Edible Grain , Avena/adverse effects , Avena/classification , Avena/immunology , Celiac Disease/diagnosis , Celiac Disease/immunology , Clinical Decision-Making , Diet, Gluten-Free/adverse effects , Edible Grain/adverse effects , Edible Grain/classification , Edible Grain/immunology , Food Contamination , Gliadin/adverse effects , Gliadin/immunology , Humans , Nutritive Value , Patient Selection , Recommended Dietary Allowances , Risk AssessmentABSTRACT
Antecedentes y objetivo: La omega-5 gliadina (omega5G) se considera el alérgeno principal en la anafilaxia inducida por ejercicio dependiente del trigo (WDEIA). Estos pacientes presentan reacciones anafilácticas tras la ingesta de trigo y la realización de ejercicio físico. El objetivo de nuestro estudio es describir las principales características de 12pacientes con este diagnóstico. Materiales y métodos: Estudio descriptivo, retrospectivo, mediante revisión de historias clínicas de 12pacientes diagnosticados de hipersensibilidad a omega5G. Resultados: La edad media fue 37 años, el 50% varones y el 50% mujeres. La mayoría tenía antecedente de episodios similares sin estudiar. El tiempo de latencia variaba desde inmediato hasta 150 min. La clínica más frecuente fue la urticaria (83%), seguida de broncoespasmo (58%), angioedema (42%), hipotensión (25%) y síntomas gastrointestinales (16%). El cofactor más implicado fue el ejercicio físico. El estudio alergológico se realizó con prick test y determinación de IgE total y específicas. Conclusiones: La WDEIA es una forma de alergia alimentaria relativamente rara pero potencialmente grave, por lo que es importante su conocimiento para poder llegar a un correcto diagnóstico
Background and objectives: The omega-5 gliadin (omega5G) is considered the main allergen in wheat-dependent exercise-induced anaphylaxis (WDEIA). These patients experience anaphylactic reactions after consuming wheat and performing physical exercise. The aim of our study was to describe the main characteristics of 12 patients with this diagnosis. Material and methods: A descriptive, retrospective study was conducted by reviewing the medical records of 12 patients diagnosed with omega-5G hypersensitivity. Results: The patients' mean age was 37 years, with 50% men and 50% women. Most of the patients had a history of similar unexamined episodes. The latency period varied from immediate to 150min. The most common symptoms were urticaria (83%), bronchospasms (58%), angio-oedema (42%), hypotension (25%) and gastrointestinal symptoms (16%). The most often involved cofactor was physical exercise. The allergy study was conducted with prick tests and total and specific IgE readings. Conclusions: WDEIA is a relatively rare but potentially severe food allergy. Understanding this allergy is therefore important for a correct diagnosis
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Wheat Hypersensitivity/diagnosis , Asthma, Exercise-Induced/diagnosis , Anaphylaxis/diagnosis , Gliadin/adverse effects , Retrospective Studies , Food Hypersensitivity/diagnosis , Immunologic Factors/analysisABSTRACT
No disponible
Subject(s)
Humans , Wheat Hypersensitivity/diagnosis , Asthma, Exercise-Induced/diagnosis , Exercise , Gliadin/adverse effects , Food Hypersensitivity/epidemiology , Risk FactorsABSTRACT
Dietary gliadin may show a broad spectrum of toxicity. The interplay between mitochondria and gliadin-induced oxidative stress has not been thoroughly examined in the intestinal epithelium. In this kinetic study, Caco-2 cells were exposed for 24 h to pepsin-trypsin-digested gliadin, alone or in combination with the antioxidant 2,6-di-tbutyl-p-cresol (BHT), and the effects on mitochondrial biogenesis and mtDNA were studied. Cells ability to recover from stress was determined after 24 h and 48 h of incubation in the culture medium. Gliadin-induced oxidative stress evoked a compensatory response. The stressor triggered a rapid and significant increase of Peroxisome proliferator-activated receptor γ coactivator-1alpha (PGC-1α) and Peroxiredoxin III (PrxIII) proteins, and mtDNA amount. As for the effects of gliadin on mtDNA integrity, strand breaks, abasic sites, and modified bases were analyzed in three mtDNA regions. D-loop appeared a more fragile target than Ori-L and ND1/ND2. The temporal trend of the damage at D-loop paralleled that of the amount of mtDNA. Overall, a trend toward control values was shown 48 h after gliadin exposure. Finally, BHT was able to counteract the effects of gliadin. Results from this study highlighted the effects of gliadin-induced oxidative stress on mitochondria, providing valuable evidence that might improve the knowledge of the pathophysiology of gluten-related disorders.
Subject(s)
Antioxidants/pharmacology , Butylated Hydroxytoluene/pharmacology , Gliadin/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Oxidative Stress/drug effects , Apoptosis/drug effects , Caco-2 Cells , DNA, Mitochondrial/genetics , Gliadin/adverse effects , Humans , Mitochondria/genetics , Organelle BiogenesisABSTRACT
Celiac disease (CD) is a chronic systemic autoimmune disorder that is triggered by the ingestion of gliadin peptides, the alcohol-soluble fraction of wheat gluten. These peptides, which play a key role in the immune response that underlies CD, spontaneously form aggregates and exert a direct toxic action on cells due to the increase in the reactive oxygen species (ROS) levels. Furthermore, peptic-tryptic digested gliadin peptides (PT-gliadin) lead to an impairment in the autophagy pathway in an in vitro model based on Caco-2 cells. Considering these premises, in this study we have analyzed different mTOR-independent inducers, reporting that the disaccharide trehalose, a mTOR-independent autophagy activator, rescued the autophagy flux in Caco-2 cells treated with digested gliadin, as well as improved cell viability. Moreover, trehalose administration to Caco-2 cells in presence of digested gliadin reduced the intracellular levels of these toxic peptides. Altogether, these results showed the beneficial effects of trehalose in a CD in vitro model as well as underlining autophagy as a molecular pathway whose modulation might be promising in counteracting PT-gliadin cytotoxicity.
Subject(s)
Celiac Disease/metabolism , Trehalose/pharmacology , Autophagy/drug effects , Caco-2 Cells , Celiac Disease/immunology , Cell Survival/drug effects , Gliadin/adverse effects , Gliadin/chemistry , Gliadin/toxicity , Glutens , HT29 Cells , Humans , Models, Biological , Peptides , Reactive Oxygen Species , Trehalose/metabolism , Triticum/metabolismABSTRACT
Objective: Celiac disease is an immune-mediated disease of the intestine triggered by gluten. Gluten elicits, in genetically susceptible individuals, cytokine responses that are then transmitted to the immunocompetent cells. Vegetables and fruit have anti-inflammatory and antioxidant properties with a protective effect on intestinal epithelium. Kiwifruit is known to have beneficial effects on the intestinal tissues, and it is the only plant food containing the peptide kissper, with anti-inflammatory properties. The aim of this study was the evaluation of the kissper effect on the gluten-induced inflammation in celiac disease. Methods: We used an in vitro model of intestinal culture explant from celiac disease patients and non-celiac disease patients, cultured for 24 hours with the toxic gliadin peptide P31-43 and kissper preincubation. Results: Our data showed HLA-DR and TG2 reduction in the celiac disease mucosa pretreated with kissper, as well as a reduction of COX-2 in two patients. No differences we observed for the TGF-b1 and IL-15 levels in supernatants upon kissper pretreatment. Conclusions: The preliminary results suggest that kissper has a potential anti-inflammatory role in celiac disease.
Subject(s)
Actinidia , Anti-Inflammatory Agents/pharmacology , Celiac Disease/metabolism , Fruit , Peptides/pharmacology , Plant Proteins/pharmacology , Celiac Disease/therapy , Gliadin/adverse effects , Glutens/adverse effects , Humans , Intestinal Mucosa/drug effects , Peptide Fragments/adverse effects , Signal Transduction/drug effectsABSTRACT
BACKGROUND & AIMS: Wheat-related disorders, a spectrum of conditions induced by the ingestion of gluten-containing cereals, have been increasing in prevalence. Patients with celiac disease have gluten-specific immune responses, but the contribution of non-gluten proteins to symptoms in patients with celiac disease or other wheat-related disorders is controversial. METHODS: C57BL/6 (control), Myd88-/-, Ticam1-/-, and Il15-/- mice were placed on diets that lacked wheat or gluten, with or without wheat amylase trypsin inhibitors (ATIs), for 1 week. Small intestine tissues were collected and intestinal intraepithelial lymphocytes (IELs) were measured; we also investigated gut permeability and intestinal transit. Control mice fed ATIs for 1 week were gavaged daily with Lactobacillus strains that had high or low ATI-degrading capacity. Nonobese diabetic/DQ8 mice were sensitized to gluten and fed an ATI diet, a gluten-containing diet or a diet with ATIs and gluten for 2 weeks. Mice were also treated with Lactobacillus strains that had high or low ATI-degrading capacity. Intestinal tissues were collected and IELs, gene expression, gut permeability and intestinal microbiota profiles were measured. RESULTS: In intestinal tissues from control mice, ATIs induced an innate immune response by activation of Toll-like receptor 4 signaling to MD2 and CD14, and caused barrier dysfunction in the absence of mucosal damage. Administration of ATIs to gluten-sensitized mice expressing HLA-DQ8 increased intestinal inflammation in response to gluten in the diet. We found ATIs to be degraded by Lactobacillus, which reduced the inflammatory effects of ATIs. CONCLUSIONS: ATIs mediate wheat-induced intestinal dysfunction in wild-type mice and exacerbate inflammation to gluten in susceptible mice. Microbiome-modulating strategies, such as administration of bacteria with ATI-degrading capacity, may be effective in patients with wheat-sensitive disorders.
Subject(s)
Celiac Disease/immunology , Diet, Gluten-Free/methods , Gliadin/adverse effects , Lactobacillus/immunology , Triticum/adverse effects , Amylases/antagonists & inhibitors , Animals , Celiac Disease/diet therapy , Celiac Disease/physiopathology , Disease Models, Animal , Gastrointestinal Microbiome/immunology , Gliadin/immunology , Humans , Immunity, Innate/drug effects , Lactobacillus/metabolism , Mice , Mice, Inbred C57BL , Random Allocation , Reference Values , Sensitivity and Specificity , Triticum/immunology , Trypsin Inhibitors/immunology , Trypsin Inhibitors/pharmacologyABSTRACT
Gliadin, a component of wheat gluten known to be an important factor in the etiology of celiac disease, is related to several other diseases through its enhancing effect on intestinal paracellular permeability. We investigated the significance of gliadin in non-steroidal anti-inflammatory drug (NSAID)-induced small-intestinal damage in mice. 7-week-old C57BL/6 male mice were divided into the following groups: standard diet group, in which mice were fed with wheat-containing standard rodent diet (CE-2); gluten-free diet group, in which mice were fed with gluten-free diet (AIN-76A); and gliadin-administered group, in which mice fed with gluten-free diet were administered with gliadin (~250 mg/kg BW). Each group was subdivided into negative, healthy control group and NSAID-treated group. To some mice fed with gluten-free diet and administered with gliadin, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor was administered for clarification of the significance of EGFR in NSAID-induced small intestinal damage and intestinal permeability. In mice fed with a gluten-free diet, indomethacin or diclofenac induced very mild mucosal damage in the small intestine compared with that in mice fed with a wheat-containing standard diet. Gliadin exacerbated the NSAID-induced small-intestinal damage in mice fed with a gluten-free diet. With the administration of indomethacin, MPO activity, a marker of neutrophil infiltration into the mucosa and mRNA expression level of tumor necrosis factor α and interleukin-1ß in the small intestine were higher in the gliadin-administered mice. Gliadin increased the intestinal paracellular permeability without indomethacin administration (4.3-fold) and further increased the permeability after indomethacin administration (2.1-fold). Gliadin induced phosphorylation of epidermal growth factor receptor (EGFR) in small-intestinal tissues, and erlotinib (an EGFR tyrosine kinase inhibitor) attenuated the indomethacin-induced intestinal damage and permeability exacerbated by gliadin, accompanied by inhibition of EGFR phosphorylation. These results suggest that gliadin plays an important role in the induction and exacerbation of NSAID-induced small-intestinal damage, and that increase in intestinal permeability via the EGFR signalling pathway is involved in its mechanism.
Subject(s)
Gliadin/adverse effects , Intestine, Small/drug effects , Intestine, Small/physiopathology , Triticum/adverse effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Celiac Disease/etiology , Diclofenac/adverse effects , Diet, Gluten-Free , Disease Models, Animal , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/physiology , Erlotinib Hydrochloride/pharmacology , Glutens/adverse effects , Indomethacin/adverse effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Intestinal Mucosa/physiopathology , Intestine, Small/pathology , Male , Mice , Mice, Inbred C57BL , Permeability/drug effects , Phosphorylation , Protein Kinase Inhibitors/pharmacologyABSTRACT
The study evaluated the symptoms, acceptance, and digestibility of bread made from transgenic low-gliadin wheat, in comparison with gluten free bread, in Non-coeliac gluten sensitivity (NCGS) patients, considering clinical/sensory parameters and gut microbiota composition. This study was performed in two phases of seven days each, comprising a basal phase with gluten free bread and an E82 phase with low-gliadin bread. Gastrointestinal clinical symptoms were evaluated using the Gastrointestinal Symptom Rating Scale (GSRS) questionnaire, and stool samples were collected for gluten immunogenic peptides (GIP) determination and the extraction of gut microbial DNA. For the basal and E82 phases, seven and five patients, respectively, showed undetectable GIPs content. The bacterial 16S rRNA gene V1-V2 hypervariable regions were sequenced using the Illumina MiSeq platform and downstream analysis was done using a Quantitative Insights into Microbial Ecology (QIIME) pipeline. No significant differences in the GSRS questionnaires were observed between the two phases. However, we observed a significantly lower abundance of some gut genera Oscillospira, Dorea, Blautia, Bacteroides, Coprococcus, and Collinsella, and a significantly higher abundance of Roseburia and Faecalibacterium genera during the E82 phase compared with the basal phase. The consumption of low-gliadin bread E82 by NCGS subjects induced potentially positive changes in the gut microbiota composition, increasing the butyrate-producing bacteria and favoring a microbial profile that is suggested to have a key role in the maintenance or improvement of gut permeability.
Subject(s)
Diet, Gluten-Free/statistics & numerical data , Gastrointestinal Microbiome/physiology , Gliadin/adverse effects , Gliadin/analysis , Malabsorption Syndromes/diet therapy , Adult , Feces/chemistry , Feces/microbiology , Female , High-Throughput Nucleotide Sequencing , Humans , Male , Middle Aged , Plants, Genetically Modified/genetics , Triticum/geneticsABSTRACT
Celiac disease (CD) is a chronic immune-mediated disorder, characterized by enhanced paracellular permeability across the intestinal epithelium. The complex system of intercellular junctions, including tight junctions (TJs) and adherens junctions (AJs), seals together the epithelial cells to form a continuous layer. The improvements in barrier integrity have been related to modifications in intercellular junction protein expression. Polyamines (spermidine, spermine, and putrescine) actively participate in the modulation of the AJ expression. Both in vitro and in vivo studies have demonstrated that also probiotics can promote the integrity and the function of the intestinal barrier. On these bases, the present work investigated the protective effects exerted by Lactobacillus rhamnosus GG (L.GG) against the pepsin-trypsin-digested gliadin (PTG)-induced enteropathy in jejunal tissue samples of Wistar rats. In particular, the probiotic effects have been evaluated on the intestinal mucosal architecture, polyamine metabolism and intercellular junction protein expression (ZO-1, Occludin, Claudin-1, ß-catenin and E-cadherin). The results from this study indicate that L.GG protects the intestinal mucosa of rats from PTG-induced damage, by preventing the reduction of the expression of the intercellular junction proteins. Consequently, a role for L.GG in the therapeutic management of the gluten-related disorders in humans could be hypothesized.
Subject(s)
Gliadin/adverse effects , Intestinal Diseases/therapy , Lacticaseibacillus rhamnosus , Pepsin A/adverse effects , Probiotics , Trypsin/adverse effects , Animals , Cadherins/genetics , Cadherins/metabolism , Claudin-1/genetics , Claudin-1/metabolism , Epithelial Cells , Intestinal Diseases/chemically induced , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Occludin/genetics , Occludin/metabolism , Rats , Rats, Wistar , Tight Junctions/metabolism , Zonula Occludens-1 Protein/genetics , Zonula Occludens-1 Protein/metabolism , beta Catenin/genetics , beta Catenin/metabolismABSTRACT
La sensibilidad al gluten no celiaca es un trastorno relevante del que no existen en la actualidad suficientes estudios científicos ni biomarcadores específicos para identificar claramente esta patología de forma separada de otros trastornos gastrointestinales. El diagnóstico tardío de este trastorno, conduce al paciente a una serie de desórdenes, no necesariamente del ámbito intestinal, que pueden desembocar en una enfermedad crónica, autoinmune, inflamatoria o neoplásica. Los síntomas del trastorno no suelen ser reportados de forma inmediata a los profesionales de la salud, dado que muchos de los pacientes afectados no los consideran de relevancia dentro de su patología de base, igualmente, no los relacionan con una posible sensibilidad al gluten, o creen que estos problemas son derivados de la edad o de otras situaciones (malas digestiones, comidas copiosas, efectos adversos a la medicación). Por otro lado, los análisis realizados a los pacientes que presentan estos síntomas para descartar una posible celiaquía o una intolerancia alimentaria, suelen dar negativos, descartando de entrada que el gluten esté implicado en estos trastornos. Esto hace que sea una enfermedad que puede afectar de forma sutil al organismo, y que podría conllevar complicaciones más graves (AU)
The Non-Celiac Gluten Sensibility is a relevant disorder that there are not enough scientific studies and specific biomarkers to identify strictly this pathology separately from others gastrointestinal disorders. The later diagnosis could lead to a number of pathologies, not necessarily in the intestinal area, which can lead to a chronic, autoimmune, inflammatory or neoplastic disease. The symptoms are not usually reported immediately to healthcare professionals, given that many of the affected patients do not consider relevant in its base pathology, likewise not relate to a possible sensitivity to gluten, or they believe that these problems are derived from age or other situations (indigestion, heavy meals, medication side effects). Furthermore, tests performed to patients with these symptoms to rule out celiac disease or food intolerance, often are negative discarding that gluten is involved in these disorders. This makes it a disease that is affecting slowly patients health that could lead to more serious complications (AU)
Subject(s)
Humans , Diet, Gluten-Free , Glutens/adverse effects , Gliadin/adverse effects , Celiac Disease/diagnosis , Food Hypersensitivity/diagnosis , Wheat Hypersensitivity/diagnosisABSTRACT
BACKGROUND: In Japan, over 2000 users of a facial soap containing Glupearl 19S (GP19S), a hydrolysed wheat protein (HWP), developed immediate-type systemic wheat allergy (HWP-IWA), and â¼70% of them developed associated contact urticaria. OBJECTIVES: We investigated whether HWP-IWA patients cross-react with other HWPs, and analysed HWP antigenic characteristics. METHODS: We used 10 types of HWP that are commercially available as cosmetic ingredients, and 16 subjects with HWP-IWA. We performed an enzyme-linked immunosorbent assay (ELISA) to evaluate the reactivity to each HWP, and western blotting to evaluate the characteristics of the antigens by using HWP-IWA patients' serum IgE antibodies. We also performed prick tests with the HWPs. RESULTS: The patients reacted to four other HWPs in addition to GP19S, according to ELISA, and this was confirmed by strong reactions in the prick tests to the same four types of HWP. Smears of antigens with molecular weights ranging from the high range to the low range were seen on western blotting with the four HWPs that showed strong reactions in the ELISA and prick tests. CONCLUSIONS: HWP-IWA patients cross-react with other HWPs. The antigens that they cross-reacted to had a molecular weight distribution similar to that of GP19S present in the HWPs.